Video & Transcript Research : 'psychoactive cannabinoids'

Page 3 of 13
TX

Texas 89th Regular

Senate Session Aug 1st, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Hemp products and the hemp-derived cannabinoids contained in those products.
  • But like them, I support age restrictions on purchases. a ban on synthetic cannabinoids, and I support
  • These synthetic cannabinoids, often chemically altered to evade regulation, pose significant risks to
  • a ban and a TCUP medical program that provides those who can get a better medical benefit from cannabinoids
Bills: SB5, SB11, SB12, SB5, SB11, SB12
NH

New Hampshire 2025 Regular Session

House Criminal Justice and Public Safety (01/23/2025)

Criminal Justice and Public Safety

Transcript Highlights:
  • I might not be the best one to explain synthetic cannabinoids.
  • The higher concentration of the THC and the other cannabinoids, but that is absolutely wonderful.
  • when you take um THC the psychoactive when you take um THC the psychoactive chemical<01:47:33.280
  • Synthetic cannabinoids is a huge issue I've been working on for a long time.
  • Cannabis has over 100 That one cannabis has over 100 potentially intoxicating cannabinoids in it.
Keywords: 1189, house, all
TX

Texas 89th 2nd C.S.

Finance Aug 15th, 2025

Finance

Bills: SB2, SB3, SB5, SB9, SB10, SB14, SB16, SB34, SB18
Summary: The Senate Committee on Finance met in the second special session and considered a series of bills, mostly related to flood response, water infrastructure, taxation, school accountability, property fraud, and legislative procedure. Senator Zaffirini presented SB 18 on TCEQ permit exemptions for certain erosion, floodwater, and sediment control dams or reservoirs; Senator Perry presented SB 2 on flood relief preparedness, SB 14 on credit impact fees and water supply/conservation incentives, and SB 5 on Hill Country relief funding; Senator Bettencourt presented SB 3 on early warning flood sirens, SB 9 on replacing STAAR with three annual tests and strengthening A-F accountability, and SB 10 on lowering the rollback tax rate from 3.5% to 2.5%; Senator West presented SB 16 on property transaction ID requirements and new real property theft/fraud offenses; and Chair Huffman laid out SB 34, which changes legislative witness immunity rules from transactional immunity to testimonial immunity consistent with federal law. The committee also heard brief explanations that several bills were the same as versions previously passed by the Senate or committee, and there was limited public testimony, with no witnesses on most bills and only position cards on SB 16. Senator West raised a concern on SB 10 about a possible carve-out for police pay raises, but Senator Bettencourt said no change would be made at that time. For SB 34, Chair Huffman explained the bill would still allow compelled testimony before the legislature but would no longer provide blanket immunity, while preserving the right to counsel. The committee voted favorably on all bills considered. SB 18, SB 2, SB 14, SB 3, SB 16, SB 5, and SB 34 were reported out unanimously or near-unanimously, while SB 9 passed 10-1 and SB 10 passed 8-3. At the end of the meeting, Senator West requested to be shown voting nay on SB 9, and the chair granted unanimous consent. The committee then recessed subject to the call of the chair.
TX

Texas 89th 1st C.S.

Senate Session (Part II) Jul 21st, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Senate Bill 5 by Obama concerns the cannabinoids contained in those products. To State Affairs.
Summary: The meeting centered around the discussion of congressional redistricting, where the committee established the procedures to ensure a fair and transparent process. Led by Senator King, the session focused on adopting a resolution that authorized a special committee dedicated to congressional redistricting and allowed for regional hearings to gather public input via videoconferencing. Concerns were raised about ensuring adequate notice for public participation, especially from marginalized communities potentially affected by proposed changes. Disagreements emerged regarding the timeline for regional hearings and how to address the implications of the redistricting process on minority districts. Overall, participants acknowledged the complex nature of redistricting and the importance of engaging constituents in the legislative process.
MA
Transcript Highlights:
  • There are hundreds of cannabinoids, most of which are non-psychoactive, and contribute to a more balanced
Keywords: 995, all
Summary: The Special Joint Committee on Initiative Petitions held a public hearing on Initiative Petition 25-10, House Bill 5002, titled “An Act to Restore a Sensible Marijuana Policy,” which would repeal Massachusetts’ adult-use cannabis legalization framework. Chairs Brendan Crighton and Kate Hogan outlined the Article 48 initiative process and explained that the committee is gathering testimony for a report to the legislature. The hearing was organized into expert, proponent, opponent, and public testimony, with written testimony accepted through March 27. The first witness, Jessica Trow of MassBudget, testified in opposition to repeal and focused on cannabis-related revenue and social equity. She said legalization has generated nearly $2 billion statewide since adult-use sales began, with revenue flowing through the Marijuana Regulation Fund, the state sales tax, and local taxes and fees. She emphasized that funds support public health, the Cannabis Control Commission’s social equity work, the Cannabis Social Equity Fund, and municipal budgets, and argued that legalization has created pathways for communities harmed by prohibition. The petition’s spokesperson, Wendy Wakeman, argued in favor of repeal, saying legalization has worsened public health, safety, and quality of life, citing higher potency, addiction, youth use, impaired driving, workplace positives, and black-market concerns. Committee members questioned her about the data sources, the will of the voters, the role of paid signature gatherers, and the petition’s funding, including out-of-state and dark-money concerns. Opponents of the initiative then testified that repeal would harm a regulated industry that has created jobs, tax revenue, and social equity opportunities. Caroline Pino of STEM, Kristen Rogers of Levia, Judith Ledbetter of Project De-Stigmatized Healthcare, and Armani White of Firehouse Dispensary/EON described their businesses, community investments, and personal reliance on cannabis, and warned that repeal would push consumers back to the illicit market and undermine equity programs. In public testimony, Lucas Thayer of the Massachusetts Cannabis Reform Coalition and Jeff Rawson, a chemist and consumer protection advocate, also opposed the measure, arguing that regulated cannabis is safer than unregulated products and that repeal would damage investments and public safety. The hearing ended after the public testimony, and the committee voted to close the hearing.
TX

Texas 89th 2nd C.S.

State Affairs Aug 15th, 2025

State Affairs

Transcript Highlights:
  • Under this bill, most of the therapeutic benefits are seen with a healthy mix of cannabinoids, not just
  • has heard on this issue with mothers coming in, they're real, but they all have to do with fake cannabinoids
  • 2011, on average, 7% of all cases reported to the national program on substance abuse deaths had a cannabinoid
  • detected, meaning about 100,000... ...had a cannabinoid detected, meaning about 110 deaths a year had
Bills: SB6, SB7, SB8, SB11, SB12, SB13, SB15, SB17
Summary: The committee first took up Senate Bill 8, the Texas Women's Privacy Act, and heard extensive public testimony both for and against the measure. Supporters, including representatives of Texas Values and Texas Values Action, argued the bill was needed to protect women’s privacy and safety in restrooms, locker rooms, showers, prisons, domestic violence shelters, and other government-controlled spaces, and said it would provide clear, sex-based rules. Opponents, including many transgender Texans, civil rights advocates, clergy, business and public safety voices, and others, argued the bill would invite harassment, gender policing, lawsuits, and invasive inspections, while harming trans, intersex, and gender-nonconforming people as well as cisgender women who do not fit stereotypes. Several witnesses said the bill would conflict with federal law or prison standards, worsen safety in shelters and prisons, and hurt Texas’s reputation and economy. The chair repeatedly noted the compressed special-session schedule and said flood relief remained the session’s top priority. Public testimony on SB 8 was eventually closed, and the bill was left pending. The committee then moved to Senate Bill 6, dealing with consumable hemp product restrictions. Testimony on SB 6 focused on whether the bill went too far in restricting hemp-derived THC products. Opponents argued hemp and THC have medical and economic value, that the bill would criminalize conduct and burden courts, and that regulation—not prohibition—was the better approach. Some witnesses supported tighter rules such as testing, child-resistant packaging, and limits on marketing to children, but still opposed the bill’s broad THC ban, higher fees, and age restrictions. Several speakers emphasized benefits for veterans, chronic pain patients, and small businesses, and warned that prohibition would push consumers toward the illicit market. The committee heard the testimony and then continued with additional witnesses, with no final vote or disposition reported in the excerpt.
TX

Texas 89th Regular

Public Health May 12th, 2025

Public Health

Transcript Highlights:
  • of prohibiting e-cigarette devices, including those that are contained in... ...mixed with any cannabinoids
  • specific training and certification requirements to prescribe and administer certain drugs, including psychoactive
CA

California 2025-2026 Regular Session

Assembly Business and Professions Committee Apr 22nd, 2025

Business and Professions

Transcript Highlights:
  • Where intoxicating cannabinoids are cheap, potent, untested and untaxed.
  • Herpeutic cannabinoids derived naturally from low-THC plants.
  • department, which opens the door for crushing political pressure on agencies to legalize other psychoactive
Keywords: 988, house, all
MN

Minnesota 2025-2026 Regular Session

Committee on Commerce and Consumer Protection - 03/24/26

Commerce and Consumer Protection

Transcript Highlights:
  • <00:07:59.280> products policy that medical cannabinoid products policy that medical cannabinoid
  • Usually focused on cannabinoid cannabidiol. You'd think I would be able to say those words by now.
  • , CBG, CBN, and other, most importantly, non-intoxicating cannabinoids.
  • To be clear, this is about non-intoxicating hemp-derived cannabinoids.
  • So, these are products that may have half and half THC, CBD, CBG, other cannabinoids.
Keywords: 1187, senate, all
NH

New Hampshire 2025 Regular Session

House Health, Human Services and Elderly Affairs (01/22/2025)

Health, Human Services & Elderly Affairs

Transcript Highlights:
  • include non intoxicating cannabinoids include non intoxicating cannabinoids such<00:08:38.159>
  • So in any case, we need these other non-intoxicating cannabinoids.
  • to Source these nontoxin cannabinoids to Source these nontoxin cannabinoids and<00:24:49.240>
  • levels of uh nontoxin cannabinoid levels of uh nontoxin cannabinoid thank<00:24:59.399> you
  • We also offer tinctures that include THC in ratio with CBD and other cannabinoids.
Keywords: 1189, house, all
CA
Transcript Highlights:
  • state legislature intended for the hemp market to evolve into a shadow market where intoxicating cannabinoids
  • Rather, the hemp market was intended to be a wellness market based on non-intoxicating therapeutic cannabinoids
  • Other psychoactive substances.
Summary: The committee heard a long agenda of bills, with most measures drawing support from industry, professional, local government, and advocacy witnesses, and several receiving committee amendments before moving forward. AB 8 on hemp and cannabis drew the most extensive debate: supporters said it would close loopholes around intoxicating hemp products, strengthen enforcement, and bring THC products into the regulated cannabis supply chain; opponents, including small cannabis farmers and environmental groups, warned it could undermine Proposition 64’s closed-loop system, harm California cultivators, and reduce tax revenues for youth, environmental, and law enforcement programs. The author said the bill was intended to protect consumers and children and to work further with stakeholders. AB 476 on copper theft was presented as a public safety and infrastructure bill to tighten reporting, documentation, and penalties for scrap metal theft; supporters from cities, utilities, broadband, and recycling-related groups described major losses and outages from copper theft, and the remaining opposition moved to neutral after amendments, with the bill advancing with committee support. The committee also heard AB 985, which would allow nationally certified anesthesiologist assistants to practice under direct supervision of licensed anesthesiologists to address anesthesia workforce shortages. Supporters, including the California Society of Anesthesiologists, medical groups, students, and patients, said it would expand access and bring California in line with other states; nurse anesthesiology groups expressed concerns and sought further clarification, but there was no formal opposition at the hearing. AB 506, aimed at online pet sales, would void contracts that fail to disclose an animal’s origin or veterinary records or that require non-refundable deposits; animal welfare groups said it would curb puppy mill pipelines and deceptive online sales, and there was no opposition. AB 876, on certified registered nurse anesthetists, generated the sharpest health care policy dispute: supporters said it would codify existing practice and clarify CRNA duties, while physicians and medical associations argued it would expand scope too far and reduce patient safety. After a roll call, AB 876 passed the committee 9-0, as amended, to Appropriations. Other bills advanced with broad support after amendments. AB 432, the Menopause Equity Act, would require continuing medical education on menopause-related care for certain physicians; the author and medical experts said the bill addresses widespread gaps in menopause treatment and research, while CMA and ACOG opposed the mandate as an inappropriate CME requirement, though they agreed the underlying problem is real. The bill passed on call, as amended, to Health. AB 759 would allow eligible architectural candidates to use the title “architect in training” to encourage completion of licensure and improve diversity in the profession; it passed unanimously, as amended, to Appropriations. AB 967 would create an optional expedited licensure fee for out-of-state physicians to reduce delays in bringing doctors into California’s workforce; supporters said it would help address shortages and improve patient access, and the bill was presented with support from medical stakeholders.
WY

Wyoming 2026 Regular Session

Senate Judiciary Committee, February 16, 2026

Judiciary

Transcript Highlights:
  • Uh, it contains two major psychoactive ingredients.
  • dangerous levels of heavy metals, and some products have included undeclared ingredients such as psychoactive
  • 01.360> psycho undeclared ingredients such as psycho undeclared ingredients such as psycho psychoactive
  • And the concentrated composition of the psychoactive ingredient 7-OH are widely available and completely
  • I just feel like it's the same thing with cannabinoids, you know, like I feel like there could be benefits
Bills: HB0103, HB0070, HB0091
WY

Wyoming 2026 Regular Session

House Judiciary Committee, February 25, 2026

Judiciary

Transcript Highlights:
  • It contains two major psychoactive ingredients, mitragynine and 7-hydroxymitragynine.
  • two major psychoactive Contains two major psychoactive ingredients,<00:57:28.720> metrogenine
  • or alcohol psychoactive substances or alcohol increasing<00:59:39.920> health<00:59:40.160>
  • You're going to have those psychoactive-type behaviors.
  • <01:07:55.119> at<01:07:55.760> at um psychoactive type behaviors. at at um psychoactive
Bills: SF0071, SF0088, SF0056
TX
Transcript Highlights:
  • has heard on this issue, with mothers coming in, they're real, but they all have to do with fake cannabinoids
  • Y'all, I've never even tried THC or weed or cannabinoid or any weed product.
  • of the population of all cases reported to the National Program on Substance Abuse Deaths had a cannabinoid